Sana Biotechnology, Inc. Common Stock (SANA) is a publicly traded Healthcare sector company. As of July 8, 2026, SANA trades at $3.94 with a market cap of $1.10B and a P/E ratio of -4.21. SANA moved -5.58% today. Year to date, SANA is +0.98%; over the trailing twelve months it is +32.90%. Its 52-week range spans $1.26 to $7.30. Analyst consensus is strong buy with an average price target of $9.80. Rallies surfaces SANA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SANA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.94 |
| Market Cap | $1.10B |
| P/E Ratio | -4.21 |
| EPS | $-0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.30 |
| 52-Week Low | $1.26 |
| Volume | 1.36M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-244.17M |
| Gross Margin | 0.00% |
6 analysts cover SANA: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.80.